APO RESEARCH · REPORT
1,3-Thiazolidine-2,4-Dione
1,3-Thiazolidine-2,4-Dione is a heterocyclic chemical substance identified by its named ring and substituent structure.
Product & engineering
Understand the product.
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1,3-Thiazolidine-2,4-Dione. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
The commercial boundary
Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.
Which supplied interfaces and acceptance criteria define 1,3-Thiazolidine-2,4-Dione?
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1,3-Thiazolidine-2,4-Dione. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
Selected research
Market Structure
Global 1,3-Thiazolidine-2,4-Dione Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global 1,3-Thiazolidine-2,4-Dione market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for 1,3-Thiazolidine-2,4-Dione is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for 1,3-Thiazolidine-2,4-Dione is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for 1,3-Thiazolidine-2,4-Dione is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for 1,3-Thiazolidine-2,4-Dione is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of 1,3-Thiazolidine-2,4-Dione include ShanDong Believe Chemical, Jinan Shengqi Pharmaceutical, Hangzhou Ribo Pharmaceutical, Dezhou Haizhi Pharma, Siwei Development Group, Sarex and Robinson Brothers, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines 1,3-Thiazolidine-2,4-Dione output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of 1,3-Thiazolidine-2,4-Dione by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global 1,3-Thiazolidine-2,4-Dione market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of 1,3-Thiazolidine-2,4-Dione and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents 1,3-Thiazolidine-2,4-Dione sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 1,3-Thiazolidine-2,4-Dione market size, projected growth trends, production technologies, key applications, and end-use industries.
1,3-Thiazolidine-2,4-Dione Segment by Company
ShanDong Believe Chemical
Jinan Shengqi Pharmaceutical
Hangzhou Ribo Pharmaceutical
Dezhou Haizhi Pharma
Siwei Development Group
Sarex
Robinson Brothers
1,3-Thiazolidine-2,4-Dione Segment by Type
Purity ≥98%
Purity ≥99%
Others
1,3-Thiazolidine-2,4-Dione Segment by Application
Pioglitazone Intermediate
Rosiglitazone Intermediate
Others
1,3-Thiazolidine-2,4-Dione Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 1,3-Thiazolidine-2,4-Dione market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 1,3-Thiazolidine-2,4-Dione and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 1,3-Thiazolidine-2,4-Dione.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the 1,3-Thiazolidine-2,4-Dione market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 1,3-Thiazolidine-2,4-Dione industry.
Chapter 3: Detailed analysis of 1,3-Thiazolidine-2,4-Dione market competition landscape. Including 1,3-Thiazolidine-2,4-Dione manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of 1,3-Thiazolidine-2,4-Dione by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of 1,3-Thiazolidine-2,4-Dione in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥98%
- Purity ≥99%
- Others
Applications
- Pioglitazone Intermediate
- Rosiglitazone Intermediate
- Others
Companies covered
- ShanDong Believe Chemical
- Jinan Shengqi Pharmaceutical
- Hangzhou Ribo Pharmaceutical
- Dezhou Haizhi Pharma
- Siwei Development Group
- Sarex
- Robinson Brothers
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global 1,3-Thiazolidine-2,4-Dione Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global 1,3-Thiazolidine-2,4-Dione Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global 1,3-Thiazolidine-2,4-Dione Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global 1,3-Thiazolidine-2,4-Dione Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global 1,3-Thiazolidine-2,4-Dione Market Dynamics
- 2.1 1,3-Thiazolidine-2,4-Dione Industry Trends
- 2.2 1,3-Thiazolidine-2,4-Dione Industry Drivers
- 2.3 1,3-Thiazolidine-2,4-Dione Industry Opportunities and Challenges
- 2.4 1,3-Thiazolidine-2,4-Dione Industry Restraints
3 1,3-Thiazolidine-2,4-Dione Market by Manufacturers
- 3.1 Global 1,3-Thiazolidine-2,4-Dione Production Value by Manufacturers (2021-2026)
- 3.2 Global 1,3-Thiazolidine-2,4-Dione Production by Manufacturers (2021-2026)
- 3.3 Global 1,3-Thiazolidine-2,4-Dione Average Price by Manufacturers (2021-2026)
- 3.4 Global 1,3-Thiazolidine-2,4-Dione Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 1,3-Thiazolidine-2,4-Dione Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global 1,3-Thiazolidine-2,4-Dione Manufacturers, Product Type & Application
- 3.7 Global 1,3-Thiazolidine-2,4-Dione Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global 1,3-Thiazolidine-2,4-Dione Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 1,3-Thiazolidine-2,4-Dione Players Market Share by Production Value in 2025
- 3.8.3 2025 1,3-Thiazolidine-2,4-Dione Tier 1, Tier 2, and Tier 3
4 1,3-Thiazolidine-2,4-Dione Market by Type
- 4.1 1,3-Thiazolidine-2,4-Dione Type Introduction
- 4.1.1 Purity ≥98%
- 4.1.2 Purity ≥99%
- 4.1.3 Others
- 4.2 Global 1,3-Thiazolidine-2,4-Dione Production by Type
- 4.2.1 Global 1,3-Thiazolidine-2,4-Dione Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global 1,3-Thiazolidine-2,4-Dione Production by Type (2021-2032)
- 4.2.3 Global 1,3-Thiazolidine-2,4-Dione Production Market Share by Type (2021-2032)
- 4.3 Global 1,3-Thiazolidine-2,4-Dione Production Value by Type
- 4.3.1 Global 1,3-Thiazolidine-2,4-Dione Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global 1,3-Thiazolidine-2,4-Dione Production Value by Type (2021-2032)
- 4.3.3 Global 1,3-Thiazolidine-2,4-Dione Production Value Market Share by Type (2021-2032)
5 1,3-Thiazolidine-2,4-Dione Market by Application
- 5.1 1,3-Thiazolidine-2,4-Dione Application Introduction
- 5.1.1 Pioglitazone Intermediate
- 5.1.2 Rosiglitazone Intermediate
- 5.1.3 Others
- 5.2 Global 1,3-Thiazolidine-2,4-Dione Production by Application
- 5.2.1 Global 1,3-Thiazolidine-2,4-Dione Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global 1,3-Thiazolidine-2,4-Dione Production by Application (2021-2032)
- 5.2.3 Global 1,3-Thiazolidine-2,4-Dione Production Market Share by Application (2021-2032)
- 5.3 Global 1,3-Thiazolidine-2,4-Dione Production Value by Application
- 5.3.1 Global 1,3-Thiazolidine-2,4-Dione Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global 1,3-Thiazolidine-2,4-Dione Production Value by Application (2021-2032)
- 5.3.3 Global 1,3-Thiazolidine-2,4-Dione Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 ShanDong Believe Chemical
- 6.1.1 ShanDong Believe Chemical Company Information
- 6.1.2 ShanDong Believe Chemical Business Overview
- 6.1.3 ShanDong Believe Chemical 1,3-Thiazolidine-2,4-Dione Production, Value and Gross Margin (2021-2026)
- 6.1.4 ShanDong Believe Chemical 1,3-Thiazolidine-2,4-Dione Product Portfolio
- 6.1.5 ShanDong Believe Chemical Recent Developments
- 6.2 Jinan Shengqi Pharmaceutical
- 6.2.1 Jinan Shengqi Pharmaceutical Company Information
- 6.2.2 Jinan Shengqi Pharmaceutical Business Overview
- 6.2.3 Jinan Shengqi Pharmaceutical 1,3-Thiazolidine-2,4-Dione Production, Value and Gross Margin (2021-2026)
- 6.2.4 Jinan Shengqi Pharmaceutical 1,3-Thiazolidine-2,4-Dione Product Portfolio
- 6.2.5 Jinan Shengqi Pharmaceutical Recent Developments
- 6.3 Hangzhou Ribo Pharmaceutical
- 6.3.1 Hangzhou Ribo Pharmaceutical Company Information
- 6.3.2 Hangzhou Ribo Pharmaceutical Business Overview
- 6.3.3 Hangzhou Ribo Pharmaceutical 1,3-Thiazolidine-2,4-Dione Production, Value and Gross Margin (2021-2026)
- 6.3.4 Hangzhou Ribo Pharmaceutical 1,3-Thiazolidine-2,4-Dione Product Portfolio
- 6.3.5 Hangzhou Ribo Pharmaceutical Recent Developments
- 6.4 Dezhou Haizhi Pharma
- 6.4.1 Dezhou Haizhi Pharma Company Information
- 6.4.2 Dezhou Haizhi Pharma Business Overview
- 6.4.3 Dezhou Haizhi Pharma 1,3-Thiazolidine-2,4-Dione Production, Value and Gross Margin (2021-2026)
- 6.4.4 Dezhou Haizhi Pharma 1,3-Thiazolidine-2,4-Dione Product Portfolio
- 6.4.5 Dezhou Haizhi Pharma Recent Developments
- 6.5 Siwei Development Group
- 6.5.1 Siwei Development Group Company Information
- 6.5.2 Siwei Development Group Business Overview
- 6.5.3 Siwei Development Group 1,3-Thiazolidine-2,4-Dione Production, Value and Gross Margin (2021-2026)
- 6.5.4 Siwei Development Group 1,3-Thiazolidine-2,4-Dione Product Portfolio
- 6.5.5 Siwei Development Group Recent Developments
- 6.6 Sarex
- 6.6.1 Sarex Company Information
- 6.6.2 Sarex Business Overview
- 6.6.3 Sarex 1,3-Thiazolidine-2,4-Dione Production, Value and Gross Margin (2021-2026)
- 6.6.4 Sarex 1,3-Thiazolidine-2,4-Dione Product Portfolio
- 6.6.5 Sarex Recent Developments
- 6.7 Robinson Brothers
- 6.7.1 Robinson Brothers Company Information
- 6.7.2 Robinson Brothers Business Overview
- 6.7.3 Robinson Brothers 1,3-Thiazolidine-2,4-Dione Production, Value and Gross Margin (2021-2026)
- 6.7.4 Robinson Brothers 1,3-Thiazolidine-2,4-Dione Product Portfolio
- 6.7.5 Robinson Brothers Recent Developments
7 Global 1,3-Thiazolidine-2,4-Dione Production by Region
- 7.1 Global 1,3-Thiazolidine-2,4-Dione Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global 1,3-Thiazolidine-2,4-Dione Production by Region (2021-2032)
- 7.2.1 Global 1,3-Thiazolidine-2,4-Dione Production by Region (2021-2026)
- 7.2.2 Global 1,3-Thiazolidine-2,4-Dione Production Forecast by Region (2027-2032)
- 7.3 Global 1,3-Thiazolidine-2,4-Dione Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global 1,3-Thiazolidine-2,4-Dione Production Value by Region (2021-2032)
- 7.4.1 Global 1,3-Thiazolidine-2,4-Dione Production Value by Region (2021-2026)
- 7.4.2 Global 1,3-Thiazolidine-2,4-Dione Production Value by Region (2027-2032)
- 7.5 Global 1,3-Thiazolidine-2,4-Dione Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America 1,3-Thiazolidine-2,4-Dione Production Value (2021-2032)
- 7.6.2 Europe 1,3-Thiazolidine-2,4-Dione Production Value (2021-2032)
- 7.6.3 Asia-Pacific 1,3-Thiazolidine-2,4-Dione Production Value (2021-2032)
- 7.6.4 South America 1,3-Thiazolidine-2,4-Dione Production Value (2021-2032)
- 7.6.5 Middle East & Africa 1,3-Thiazolidine-2,4-Dione Production Value (2021-2032)
8 Global 1,3-Thiazolidine-2,4-Dione Consumption by Region
- 8.1 Global 1,3-Thiazolidine-2,4-Dione Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global 1,3-Thiazolidine-2,4-Dione Consumption by Region (2021-2032)
- 8.2.1 Global 1,3-Thiazolidine-2,4-Dione Consumption by Region (2021-2026)
- 8.2.2 Global 1,3-Thiazolidine-2,4-Dione Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America 1,3-Thiazolidine-2,4-Dione Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America 1,3-Thiazolidine-2,4-Dione Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe 1,3-Thiazolidine-2,4-Dione Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe 1,3-Thiazolidine-2,4-Dione Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific 1,3-Thiazolidine-2,4-Dione Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific 1,3-Thiazolidine-2,4-Dione Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America 1,3-Thiazolidine-2,4-Dione Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America 1,3-Thiazolidine-2,4-Dione Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa 1,3-Thiazolidine-2,4-Dione Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa 1,3-Thiazolidine-2,4-Dione Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 1,3-Thiazolidine-2,4-Dione Value Chain Analysis
- 9.1.1 1,3-Thiazolidine-2,4-Dione Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 1,3-Thiazolidine-2,4-Dione Production Mode & Process
- 9.2 1,3-Thiazolidine-2,4-Dione Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 1,3-Thiazolidine-2,4-Dione Distributors
- 9.2.3 1,3-Thiazolidine-2,4-Dione Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst